Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to find a protein (ex. Polycystin 1 or mucin and cadherin like protein) in the urine that is changed after treatment of hydralazine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03423810
Study type Interventional
Source University of Kansas Medical Center
Contact
Status Completed
Phase Early Phase 1
Start date April 23, 2018
Completion date January 30, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04039061 - ADPKD Patient Registry
Enrolling by invitation NCT05215964 - The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
Recruiting NCT01680250 - Sirolimus for Massive Polycystic Liver Phase 2/Phase 3
Completed NCT00286156 - Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Phase 1/Phase 2
Not yet recruiting NCT06036992 - Study and Management of Cystic Complications in Autosomal Dominant Polycystic Kidney Disease
Terminated NCT01009957 - Everolimus on CKD Progression in ADPKD Patients Phase 2/Phase 3
Completed NCT01931644 - At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed NCT02739750 - Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Completed NCT03889392 - Evaluation of Nephrectomy Specimen for Intracranial Aneurysm Development in ADPKD
Completed NCT03948113 - Outcome of Autosomal Dominant Polycystic Kidney Disease Patients on Peritoneal Dialysis: a National Retrospective Study Based on Two French Registries (the French Language Peritoneal Dialysis Registry and the French Renal Epidemiology and Information Network).
Recruiting NCT03726463 - Evaluation of Iliac and Renal Artery for Mechanism of Intracranial Aneurysm in ADPKD